Certara, Inc. – NASDAQ:CERT
Certara stock price today
$11.02
+0.33
+3.09%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 5 hours
Certara stock price monthly change
-29.58%
month
Certara stock price quarterly change
-29.58%
quarter
Certara stock price yearly change
-40.81%
year
Certara key metrics
Market Cap | 1.70B |
Enterprise value | 3.72B |
P/E | 256.89 |
EV/Sales | 11.09 |
EV/EBITDA | 41.83 |
Price/Sales | 10.87 |
Price/Book | 3.38 |
PEG ratio | 1.25 |
EPS | -0.38 |
Revenue | 360.69M |
EBITDA | 68.69M |
Income | -61.39M |
Revenue Q/Q | 7.03% |
Revenue Y/Y | 4.73% |
Profit margin | 4.39% |
Oper. margin | 9.69% |
Gross margin | 60.5% |
EBIT margin | 9.69% |
EBITDA margin | 19.04% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCertara stock price history
Certara stock forecast
Certara financial statements
Average Price Target
$14.5
Potential upside: 31.57%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 90.45M | 4.70M | 5.2% |
|---|---|---|---|
| Sep 2023 | 85.57M | -48.96M | -57.22% |
| Dec 2023 | 88.01M | -12.45M | -14.15% |
| Mar 2024 | 96.65M | -4.68M | -4.85% |
| Jun 2023 | 1572220000 | 475.04M | 30.21% |
|---|---|---|---|
| Sep 2023 | 1526821000 | 475.07M | 31.11% |
| Dec 2023 | 1563140000 | 516.29M | 33.03% |
| Mar 2024 | 1542378000 | 488.02M | 31.64% |
| Jun 2023 | 18.05M | -11.73M | -6.42M |
|---|---|---|---|
| Sep 2023 | 31.41M | -4.04M | -925K |
| Dec 2023 | 23.32M | -61.04M | -1.25M |
| Mar 2024 | 4.29M | -3.57M | -10.34M |
Certara alternative data
| Aug 2023 | 1,150 |
|---|---|
| Sep 2023 | 1,150 |
| Oct 2023 | 1,150 |
| Nov 2023 | 1,150 |
| Dec 2023 | 1,150 |
| Jan 2024 | 1,150 |
| Feb 2024 | 1,150 |
| Mar 2024 | 1,338 |
| Apr 2024 | 1,338 |
| May 2024 | 1,338 |
| Jun 2024 | 1,338 |
| Jul 2024 | 1,338 |
Certara other data
44.61%
-14.18%
of CERT is owned by hedge funds
151
-39
71.08M
-22.72M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 0 | 5000 |
| Jun 2023 | 0 | 19104 |
| Aug 2023 | 5000 | 0 |
| Sep 2023 | 0 | 51224 |
| Dec 2023 | 0 | 6000 |
| Feb 2024 | 0 | 11000 |
| Mar 2024 | 0 | 3000 |
| Apr 2024 | 0 | 17427 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 29 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 8 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. William F. Feehery Ph.D. (1971) Chief Executive Officer & Director | $1,390,000 |
Mr. M. Andrew Schemick (1974) Chief Financial Officer | $607,210 |
| Mr. Leif E. Pedersen (1964) Pres of Software | $295,400 |
Buy Certara After The FDA Announcement
Certara: Applied BioMath Acquisition And Simcyp Launch Should Drive Growth
Circling Back On Certara
Certara Grows But Smaller Clients May Dampen Its Growth Prospects
Why Certara Is A Buy For 2023
Allscripts Healthcare Solutions: The Picture Is Improving
Certara Looks Positioned For Increased Growth In 2022
After Its Stock Price Doubled Last Year, Why Schrödinger Is Slumping Now
Certara: Global Biosimulation Firm Positions Itself For Stability Into The Long Term
-
What's the price of Certara stock today?
One share of Certara stock can currently be purchased for approximately $11.02.
-
When is Certara's next earnings date?
Unfortunately, Certara's (CERT) next earnings date is currently unknown.
-
Does Certara pay dividends?
No, Certara does not pay dividends.
-
How much money does Certara make?
Certara has a market capitalization of 1.70B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5.57% to 354.34M US dollars.
-
What is Certara's stock symbol?
Certara, Inc. is traded on the NASDAQ under the ticker symbol "CERT".
-
What is Certara's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Certara?
Shares of Certara can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Certara's key executives?
Certara's management team includes the following people:
- Dr. William F. Feehery Ph.D. Chief Executive Officer & Director(age: 54, pay: $1,390,000)
- Mr. M. Andrew Schemick Chief Financial Officer(age: 51, pay: $607,210)
- Mr. Leif E. Pedersen Pres of Software(age: 61, pay: $295,400)
-
How many employees does Certara have?
As Jul 2024, Certara employs 1,338 workers.
-
When Certara went public?
Certara, Inc. is publicly traded company for more then 4 years since IPO on 11 Dec 2020.
-
What is Certara's official website?
The official website for Certara is certara.com.
-
Where are Certara's headquarters?
Certara is headquartered at 100 Overlook Center, Princeton, NJ.
-
How can i contact Certara?
Certara's mailing address is 100 Overlook Center, Princeton, NJ and company can be reached via phone at +60 9 716 7900.
-
What is Certara stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for Certara in the last 12 months, the avarage price target is $14.5. The average price target represents a 31.57% change from the last price of $11.02.
Certara company profile:
Certara, Inc.
certara.comExchange:
NASDAQ
Full time employees:
1,338
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
100 Overlook Center
Princeton, NJ 08540
Princeton, NJ 08540
CIK: 0001827090
ISIN: US15687V1098
CUSIP: 15687V109
